From 2023 to 2028, the standardized rates of neoplasms mortality in the US show a decline, with values decreasing from 150.4 to 140.5 per 100,000 women. The annual reduction percentage is 1.67% between 2024 and 2025, 1.76% between 2025 and 2026, 1.65% between 2026 and 2027, and 1.68% between 2027 and 2028. The five-year compound annual growth rate (CAGR) shows an average decrease of 1.72% per year.
Future trends to watch for include advancements in early cancer detection and personalized treatment approaches, which can contribute to continuing this declining trend in neoplasms mortality. Additionally, lifestyle changes and preventative healthcare policies may further reduce mortality rates.
